✦ LIBER ✦

Enhanced effects of adriamycin by combination with a new ribonucleotide reductase inhibitor, trimidox, in murine leukemia

✍ Scribed by Monika Fritzer-Szekeres; Ladislav Novotny; Darina Romanova; Rainer Göbl; Jan Sedlak; Anna Vachalkova; Peter Rauko; Howard L Elford; Thomas Szekeres

Book ID: 117175806
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 548 KB
Volume: 63
Category: Article
ISSN: 0024-3205
DOI: 10.1016/s0024-3205(98)00305-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potentiation of the activity of cisplati

Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice

✍ Ladislav Novotny; Peter Rauko; Jan Liska; Howard L. Elford; Thomas Szekeres 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Trimidox, an inhibitor of ribonucleotide

Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells

✍ Monika Fritzer-Szekeres; Alexandra Salamon; Michael Grusch; Zsuzsanna Horvath; T 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Enhancement of hemoglobin and F-cell pro

Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin

✍ Iyamu, W.E.; Adunyah, S.E.; Fasold, H.; Horiuchi, K.; Elford, H.L.; Asakura, T.; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 650 KB

Upon appropriate drug treatment, the human erythroleukemic K562 cells have been shown to produce hemoglobin and F-cells. Fetal hemoglobin (Hb F) inhibits the polymerization events of sickle hemoglobin (Hb S), thereby ameliorating the clinical symptoms of sickle cell disease. Ribonucleotide reductase

Biochemical Modulation of Aracytidine (A

Biochemical Modulation of Aracytidine (Ara-C) Effects by GTI-2040, a Ribonucleotide Reductase Inhibitor, in K562 Human Leukemia Cells

✍ Ping Chen; Josephine Aimiuwu; Zhiliang Xie; Xiaohui Wei; Shujun Liu; Rebecca Kli 📂 Article 📅 2010 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 471 KB

A Phase I study of the novel ribonucleot

A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders

✍ Judith E. Karp; Francis J. Giles; Ivana Gojo; Lawrence Morris; Jacqueline Greer; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Antiretroviral activity of ribonucleotid

Antiretroviral activity of ribonucleotide reductase inhibitors hydroxyurea, didox and trimidox in the in vivo Rauscher murine leukemia virus (RMuLV) model: PL. Black1, S. C. Kunder1, B. E. Hall1, H.L. Elford2, and M. A. Ussery1. 1U.S.ED.A., Rockville, MD; 2Molecules for Health, Richmond, VA

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 85 KB